Brian Schumer joins SOFIE as Chief Operating Officer
We are excited to welcome Brian Schumer to the SOFIE team. Brian joins SOFIE […]
SOFIE affiliate, iTheranostics, executes agreement for its promising library of Fibroblast Activation Protein (FAP) targeted theranostics
- Novartis has acquired global development and commercial rights to therapeutic applications for iTheranostics’ library […]
SOFIE Inc. enters into partnership with AUGMENTICON™
AUGMENTICON™, a privately held technology company developing Augmented-/Mixed-Reality (AR-/MR)-tools for a cost-effective, high-quality manufacturing […]
FAPI-74 PET/CT Using Either 18 F-AlF or Cold-Kit 68 Ga Labeling: Biodistribution, Radiation Dosimetry, and Tumor Delineation in Lung Cancer Patients GalleryFAPI-74 PET/CT Using Either 18 F-AlF or Cold-Kit 68 Ga Labeling: Biodistribution, Radiation Dosimetry, and Tumor Delineation in Lung Cancer Patients
![68 Ga-NOTA-FAPI-04 PET/CT in a patient with primary gastric diffuse large B cell lymphoma: comparisons with [ 18 F] FDG PET/CT](data:image/svg+xml;nitro-empty-id=NjMwOjg3Nw==-1;base64,PHN2ZyB2aWV3Qm94PSIwIDAgMjkwIDE1OCIgd2lkdGg9IjI5MCIgaGVpZ2h0PSIxNTgiIHhtbG5zPSJodHRwOi8vd3d3LnczLm9yZy8yMDAwL3N2ZyI+PC9zdmc+)
![[ 18 F]FDG and [68 Ga]Ga-DOTA-FAPI-04 PET/CT in the evaluation of tuberculous lesions](data:image/svg+xml;nitro-empty-id=NzQ5OjEwMTM=-1;base64,PHN2ZyB2aWV3Qm94PSIwIDAgNjg1IDMxMiIgd2lkdGg9IjY4NSIgaGVpZ2h0PSIzMTIiIHhtbG5zPSJodHRwOi8vd3d3LnczLm9yZy8yMDAwL3N2ZyI+PC9zdmc+)
